Lymphocyte expansion in bioreactors : upgrading adoptive cell therapy
Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing process that is able to control cell growth and functionality towards therapy affordability and opportunity. In this review, we discuss and compare current bioreactor technologies by performing a systematic analysis of the published data on automated lymphocyte expansion for adoptive cell therapy. We propose a set of requirements for bioreactor design and identify trends on the applicability of these technologies, highlighting the specific challenges and major advancements for each one of the current approaches of expansion along with the opportunities that lie in process intensification. We conclude on the necessity to develop targeted solutions specially tailored for the specific stimulation, supplementation and micro-environmental needs of lymphocytes' cultures, and the benefit of applying knowledge-based tools for process control and predictability.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Journal of biological engineering - 15(2021), 1 vom: 13. Apr., Seite 13 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Garcia-Aponte, Oscar Fabian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ATMP |
|---|
| Anmerkungen: |
Date Revised 17.04.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s13036-021-00264-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324044798 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324044798 | ||
| 003 | DE-627 | ||
| 005 | 20231225185500.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13036-021-00264-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1080.xml |
| 035 | |a (DE-627)NLM324044798 | ||
| 035 | |a (NLM)33849630 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Garcia-Aponte, Oscar Fabian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lymphocyte expansion in bioreactors |b upgrading adoptive cell therapy |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.04.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing process that is able to control cell growth and functionality towards therapy affordability and opportunity. In this review, we discuss and compare current bioreactor technologies by performing a systematic analysis of the published data on automated lymphocyte expansion for adoptive cell therapy. We propose a set of requirements for bioreactor design and identify trends on the applicability of these technologies, highlighting the specific challenges and major advancements for each one of the current approaches of expansion along with the opportunities that lie in process intensification. We conclude on the necessity to develop targeted solutions specially tailored for the specific stimulation, supplementation and micro-environmental needs of lymphocytes' cultures, and the benefit of applying knowledge-based tools for process control and predictability | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a ATMP | |
| 650 | 4 | |a Adoptive cell therapy | |
| 650 | 4 | |a Bioreactor | |
| 650 | 4 | |a Expansion | |
| 650 | 4 | |a Lymphocyte | |
| 650 | 4 | |a NK cell | |
| 650 | 4 | |a Perfusion reactor | |
| 650 | 4 | |a Rocking motion | |
| 650 | 4 | |a Stirred reactor | |
| 650 | 4 | |a T cell | |
| 700 | 1 | |a Herwig, Christoph |e verfasserin |4 aut | |
| 700 | 1 | |a Kozma, Bence |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of biological engineering |d 2007 |g 15(2021), 1 vom: 13. Apr., Seite 13 |w (DE-627)NLM17759067X |x 1754-1611 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2021 |g number:1 |g day:13 |g month:04 |g pages:13 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13036-021-00264-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2021 |e 1 |b 13 |c 04 |h 13 | ||